Rocket Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Rocket Pharmaceuticals, Inc. (RCKT) had Shares Outstanding (Cover Page) of 109.77 million shares as of 2026-07-31, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-07-31: Entity Common Stock, Shares Outstanding 109.77M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 109.19M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 108.57M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 108.22M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 109.77M shares 10-Q · filed 2026-08-10 |
| 2026-05-01 | 109.19M shares 10-Q · filed 2026-05-07 |
| 2026-02-20 | 108.57M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 108.22M shares 10-Q · filed 2025-11-06 |
| 2025-08-01 | 107.90M shares 10-Q · filed 2025-08-07 |
| 2025-05-02 | 107.74M shares 10-Q · filed 2025-05-08 |
| 2025-02-21 | 106.63M shares 10-K · filed 2025-02-27 |
| 2024-11-05 | 91.16M shares 10-Q · filed 2024-11-07 |
| 2024-08-02 | 90.98M shares 10-Q · filed 2024-08-06 |
| 2024-05-01 | 90.78M shares 10-Q · filed 2024-05-07 |
| 2024-02-22 | 90.50M shares 10-K · filed 2024-02-27 |
| 2023-11-03 | 90.16M shares 10-Q · filed 2023-11-07 |
| 2023-08-04 | 80.53M shares 10-Q · filed 2023-08-09 |
| 2023-05-01 | 80.46M shares 10-Q · filed 2023-05-05 |
| 2023-02-22 | 79.35M shares 10-K · filed 2023-02-28 |
| 2022-11-01 | 75.68M shares 10-Q · filed 2022-11-04 |
| 2022-08-05 | 66.04M shares 10-Q · filed 2022-08-09 |
| 2022-05-02 | 65.84M shares 10-Q · filed 2022-05-06 |
| 2022-02-22 | 64.51M shares 10-K · filed 2022-02-28 |
| 2021-11-04 | 64.44M shares 10-Q · filed 2021-11-05 |
| 2021-08-02 | 63.62M shares 10-Q · filed 2021-08-09 |
| 2021-05-03 | 63.40M shares 10-Q · filed 2021-05-10 |
| 2021-02-22 | 61.78M shares 10-K · filed 2021-03-01 |
| 2020-11-02 | 55.23M shares 10-Q · filed 2020-11-06 |
| 2020-08-03 | 55.19M shares 10-Q · filed 2020-08-05 |
| 2020-05-04 | 55.16M shares 10-Q · filed 2020-05-08 |
| 2020-03-02 | 55.07M shares 10-K · filed 2020-03-06 |
| 2019-11-04 | 50.38M shares 10-Q · filed 2019-11-08 |
| 2019-08-05 | 50.35M shares 10-Q · filed 2019-08-08 |
| 2019-05-06 | 50.29M shares 10-Q · filed 2019-05-09 |
| 2019-03-01 | 45.11M shares 10-K · filed 2019-03-08 |
| 2018-11-08 | 39.84M shares 10-Q · filed 2018-11-09 |
| 2018-08-13 | 39.66M shares 10-Q · filed 2018-08-14 |
| 2018-05-10 | 39.48M shares 10-Q · filed 2018-05-11 |
| 2018-03-01 | 39.40M shares 10-K · filed 2018-03-07 |
| 2017-11-03 | 27.22M shares 10-Q · filed 2017-11-08 |
| 2017-08-03 | 27.01M shares 10-Q · filed 2017-08-03 |
| 2017-05-09 | 26.99M shares 10-Q · filed 2017-05-10 |
| 2017-03-15 | 26.99M shares 10-K · filed 2017-03-16 |
| 2016-11-08 | 26.93M shares 10-Q · filed 2016-11-09 |
| 2016-08-09 | 26.93M shares 10-Q · filed 2016-08-10 |
| 2016-05-10 | 26.42M shares 10-Q · filed 2016-05-11 |
| 2016-03-22 | 26.42M shares 10-K · filed 2016-03-23 |
| 2015-11-11 | 26.41M shares 10-Q · filed 2015-11-12 |
| 2015-08-06 | 20.20M shares 10-Q · filed 2015-08-07 |
| 2015-05-13 | 16.33M shares 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |